Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Pediatrix Medical (MD) EBIT (2016 - 2025)

Historic EBIT for Pediatrix Medical (MD) over the last 17 years, with Q3 2025 value amounting to $68.1 million.

  • Pediatrix Medical's EBIT rose 10117.36% to $68.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $199.3 million, marking a year-over-year increase of 19080.43%. This contributed to the annual value of -$68.7 million for FY2024, which is 103857.4% down from last year.
  • As of Q3 2025, Pediatrix Medical's EBIT stood at $68.1 million, which was up 10117.36% from $59.9 million recorded in Q2 2025.
  • Over the past 5 years, Pediatrix Medical's EBIT peaked at $68.1 million during Q3 2025, and registered a low of -$157.7 million during Q2 2024.
  • Its 5-year average for EBIT is $25.0 million, with a median of $39.3 million in 2024.
  • Its EBIT has fluctuated over the past 5 years, first soared by 18736.99% in 2021, then tumbled by 42521.55% in 2024.
  • Pediatrix Medical's EBIT (Quarter) stood at $68.0 million in 2021, then crashed by 47.01% to $36.0 million in 2022, then tumbled by 409.37% to -$111.5 million in 2023, then surged by 135.24% to $39.3 million in 2024, then soared by 73.2% to $68.1 million in 2025.
  • Its last three reported values are $68.1 million in Q3 2025, $59.9 million for Q2 2025, and $32.1 million during Q1 2025.